Suggestions
Daniel Goldberg
Co-Founder and Principal at Bridge Investments & Palo Santo
Daniel Goldberg is a co-founder and partner at Palo Santo, a venture capital fund focused on psychedelic therapeutics.12 He is an experienced investor with a background in technology and consumer products.3 Here are key details about Daniel Goldberg:
Professional Experience
- Co-founder and Partner at Palo Santo (May 2020 - Present)1
- Co-founder and Principal at Bridge Venture Fund / Bridge Investments (1998 - Present)1
- Board Advisor for haku (March 2018 - Present)1
- Previously served as Board Director for companies like QDiscovery, FreightWatch International, and PV Media Group1
Palo Santo
Palo Santo is a venture capital fund that invests in companies developing psychedelic medicines and therapies for mental health treatment.2 The fund:
- Closed a $50 million investment fund in October 20222
- Has invested in over 20 portfolio companies across the psychedelic ecosystem2
- Aims to drive clinical development and FDA approval of psychedelic therapies2
Background and Motivation
- Goldberg's interest in psychedelics was sparked after reading Michael Pollan's book "How to Change Your Mind"3
- He has been actively involved in the psychedelic space for about four years5
- His passion for psychedelic therapeutics is described as purpose-driven and science-informed4
Education
- Bachelor of Science (B.S.) from the University of Michigan (1990 - 1994)1
Daniel Goldberg combines his investing experience with a deep network in the psychedelic research and business communities, supporting the development of innovative mental health treatments.5
Highlights
Oct 1 · thenetwork.com
Daniel Goldberg - The Network
Mar 12 · schedule.sxsw.com
Daniel Goldberg - SXSW 2023 Schedule
Dec 9 · vcsheet.com
Daniel Goldberg - Bridge Investments - VC Sheet
Sep 15 · palosantosupply.co
Palo Santo Supply Co. | Shop Palo Santo Wood & Essential Oil
Sep 13 · grownin.com
Palo Santo co-founder Daniel Goldberg talks psychedelics ...
Jul 19 · FinSMEs
Palo Santo Launches $35M Psychedelic Healthcare Venture Capital Fund - FinSMEs
Jul 19 · Crain's Chicago Business
Alzheimer's drug • JAMA retracts mask-CO2 research • Psychedelic care VC fund - Crain's Chicago Business
Jan 1 · signal.nfx.com
Daniel Goldberg - Bridge Investments Principal - Signal NFX

